Boston Scientific Brings Remote Clinical Support To Europe, Africa And Middle East

Telefónica España subsidiary TedCas signed a deal with Boston Scientific to provide telecommunications technology to Boston Scientific’s new Remote Clinical Support Centre (RhythmCare) in Madrid and provide remote support to hospitals in Europe, Africa and the Middle East.

Abstract heart made of electric lighting effect
• Source: Shutterstock

Boston Scientific will collaborate with TedCas, a subsidiary of telecommunications giant Telefónica España, to pilot a remote electrophysiology control system at Boston Scientific’s new RhythmCare support center in Madrid.

The system will collect data from electrophysiology devices and deliver it to physicians at hospitals in Europe, Africa and the...

More from Patient Monitoring

X-ray Regulations Detailed In New FDA Guidance

 

The US FDA has published final guidance to provide clarification for industry and agency staff on federal regulations of diagnostic X-ray equipment.

Altoida’s Vision For Alzheimer’s Care Combines Digital Screening, Blood-Based Tests, New Drugs

 
• By 

Altoida CEO Marc Jones spoke with Medtech Insight about the company’s investigational digital screening tool for Alzheimer’s and the dire need for better, more accessible precision neurology diagnostics as the global population ages, neurologist shortages worsen, and groundbreaking Alzheimer’s drugs change the treatment paradigm.

FDA Publishes Final Guidance For Sponsors Of Decentralized Clinical Trials

 

The US FDA is providing recommendations for sponsors conducting clinical trials outside traditional settings, such as individual homes, mobile research units, and remotely via telehealth participation. The agency says the guidance is part of an overall effort to advance how trials are designed and run.

BD Sees Bright Future For Edwards’ Critical Care, Now BD Advanced Patient Monitoring

 

Edwards Lifesciences’ Critical Care business “invented the hemodynamic monitoring category, and its solutions are currently used in more than 10,000 hospitals globally to better understand the cardiovascular condition in real-time for critically ill patients, which helps improve outcomes,” says BD, which sees synergies and new innovation opportunities across the groups’ data sets and platforms. Acquired for $4.2bn cash, Critical Care generated more than $900m in revenue in 2023.

More from Device Area